Biobud Ltd. engages in the development of biopharmaceuticals for cardiovascular prevention, diagnosis and treatment. The company was founded on March 28, 2000, and is headquartered in Seongnam, South Korea.

Shanghai Tenry Pharmaceutical Company Limited (Tenry) has set up two modernized pharmaceutical manufacturing plants based in Shanghai. As an advanced technology enterprise in Shanghai, Tenry keeps focus on the production of biopharmaceuticals, pharmaceutical raw materials and chemical drugs as well as Sales & Marketing; Research & Development and Regulatory area.

Broad Life Sciences (Liaoning) Co., Ltd., established on 1997-11-07, Business scope includes licensed business items:No general operating items:medicine,medical instruments,Research and development of biological products;R&D and production of fine chemicals;small volume injection,API,Class III medical device(6858medical cold therapy,low temperature,Refrigeration equipment and appliances)Production(It can only be operated after the approval of the competent industry department);Acquisition of agricultural and sideline products(personal use,Except for species prohibited or restricted by the state)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.

Zhaoke Pharmaceutical (Hefei) Co., Ltd., established on 1994-02-07, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Drug import and export;Disinfectant production(Free of Hazardous Chemicals);Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Disinfectant sales(Free of Hazardous Chemicals);Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Part of Siemens AG, Siemens Healthcare Diagnostics Products GmbH is a German company located in Marburg that manufactures and supplies healthcare diagnosis and monitoring equipment. It was founded in 1996. J��rg Berner and Michael Heinold are the current co-CEOs of the firm.

Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of bio-pharmaceutical products. It offers natural or biotechnology products for the treatment of cardiovascular and cerebrovascular diseases as well as two-way immunomodulatory. The company was founded on May 20, 1999 and is headquartered in Beijing, China.

Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. Qilu focuses on the development, manufacturing and marketing of generic drugs and active pharmaceutical ingredients(APIs) in therapeutic areas including but not limited to Oncology, Cerebrovascular & Cardiovascular, Anti-infections, Psychological & Neurological Systems, Respiratory System, and Ophthalmological Diseases. Qilu has more than 15,000 employees, 70% of whom have a college degree or above. Qilu Pharmaceutical consistently focuses on revolutionary development strategies guided by market demand and product innovation. Qilu has established extensive cooperation with domestic and international partners on multiple R&D projects. Devoted to the cultivation of talent, Qilu has invested in a highly qualified R&D team and efficient R&D capabilities. The 200+ new drug products successfully developed by Qilu constitutes as a large part of future production and sales for Qilu Pharmaceutical and partners. A number of technological achievements have garnered national and provincial scientific and technological progress awards for Qilu.

Shanghai Yingsheng Medical Technology Co., Ltd., established on 2005-12-26, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:medical implant material,Catheters related to interventional therapy,Scaffolding research,to develop,transfer of own technology,And provide relevant technical consultation and technical services;Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenyang Shouzheng Biotechnology Co., Ltd., established on 2017-02-04, Business scope includes biological products,medicine,medical instruments,Research and development of fine chemical products,technical consulting,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Nissho is a general freight vehicle transportation firm.

Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP

Shanghai Wanxing Bio-pharmaceuticals Co., Ltd., part of Logiq, Inc., is a company headquartered in Shanghai, China. The firm manufactures and distributes pharmaceuticals.

Zhaoyan (Suzhou) New Drug Research Center Co., Ltd., established on 2008-12-11, The scope of business includes the technical research and development of biomedicine by undertaking service outsourcing,technology transfer,Technical Services,Testing service;Production and sales of experimentalSPFclass large,mouse;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).((Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Conference and Exhibition Services;Information Consulting Service(Not including licensing information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co., Ltd., established on 2004-02-23, The business scope includes the production of oral solid dosage forms,large volume injection,small volume injection.Production and sale of Chinese food(cold meat),sell wine,drinks;stay;Mass sellingKTV(Limited to branch operations);technology transfer,Technical Services,technical consulting;Sales of daily necessities,sporting goods,Wujinjiaodian,Equipment,crafts,cosmetic,hygiene products;Import and export,Technology Import and Export,Agent import and export;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%.

Shanghai Yuanke Industrial Development Co., Ltd., established on 2014-04-18, The scope of business includes the production of medical devices and in vitro diagnostic reagents and detectors,Biotechnology,Technology development in the field of detection technology,technology transfer,technical consulting,Technical Services,Instrumentation,Sales of communication equipment,Computer software development and sales,Business Consulting,Landscaping,storage(In addition to dangerous goods),Engaged in the import and export of goods and technology,Medical device management,Telecommunications business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Manufactures and distributes surgical appliances